{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:54:20Z","timestamp":1791575660937,"version":"4.3.4"},"reference-count":132,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,5]],"date-time":"2027-10-05T00:00:00Z","timestamp":1822694400000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R01MD017816"],"award-info":[{"award-number":["R01MD017816"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.iac.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:22:59Z","timestamp":1785982979000},"page":"699-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in the Phenotyping and Management of Common Variable Immunodeficiency"],"prefix":"10.1016","volume":"46","author":[{"given":"Mikaela E.","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Jogdand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Schissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Sing","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Barmettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn R.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaip.2016.02.023","article-title":"Diagnostic criteria for common variable immunodeficiency disorders","volume":"4","author":"Ameratunga","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2021.03.005","article-title":"State-of-the-art diagnostic evaluation of common variable immunodeficiency","volume":"127","author":"Lee","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib3","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10875-007-9105-z","article-title":"Primary immunodeficiency diseases in Australia and New Zealand","volume":"27","author":"Kirkpatrick","year":"2007","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8416124","article-title":"Global distribution of common variable immunodeficiency (CVID) in the light of the UNDP human development index (HDI): a preliminary perspective of a rare disease","volume":"2020","author":"Weifenbach","year":"2020","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.iac.2026.06.011_bib8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/sji.12551","article-title":"Identification and characterization of a nationwide danish adult common variable immunodeficiency cohort","volume":"85","author":"Westh","year":"2017","journal-title":"Scand J Immunol"},{"issue":"9","key":"10.1016\/j.iac.2026.06.011_bib10","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1007\/s10620-025-09106-8","article-title":"Gastrointestinal manifestations of common variable immunodeficiency: a mentored review","volume":"70","author":"Ahmed","year":"2025","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib11","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250157","article-title":"A systematic literature review of CVID reveals pervasive detrimental noninfectious manifestations","volume":"2","author":"Ducasa","year":"2026","journal-title":"J Hum Immun"},{"issue":"10","key":"10.1016\/j.iac.2026.06.011_bib12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/1744666X.2019.1658523","article-title":"Malignancy in common variable immunodeficiency: a systematic review and meta-analysis","volume":"15","author":"Kiaee","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.iac.2026.06.011_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.46497\/ArchRheumatol.2024.10729","article-title":"Common variable immunodeficiency and autoimmune diseases: a 10-year single-center experience","volume":"39","author":"Sadi Aykan","year":"2024","journal-title":"Arch Rheumatol"},{"issue":"8","key":"10.1016\/j.iac.2026.06.011_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10875-024-01781-y","article-title":"A cross-sectional study of health-related quality of life in patients with predominantly antibody deficiency","volume":"44","author":"Elmoursi","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108931","article-title":"Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden","volume":"236","author":"Anderson","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib17","unstructured":"Grigoriadou S, Iluissoon A, Kumararatne D, et al., PY - 2010\/04\/01 SP - 8 EP - 8 T1 - Is there a delay in the diagnosis of Primary Immunodeficiency (PID)?\" Advisory Group. In: Vol 160. Wiley blackwell publishing inc; MA, USA, 2010:8-8."},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/1744666X.2015.1029457","article-title":"Economic burden of common variable immunodeficiency: annual cost of disease","volume":"11","author":"Sadeghi","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathmechdis-031521-024229","article-title":"Common variable immunodeficiency: more pathways than roads to rome","volume":"18","author":"Peng","year":"2023","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13223-022-00661-7","article-title":"Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review","volume":"18","author":"Lee","year":"2022","journal-title":"Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib21","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jaip.2025.03.009","article-title":"Uncovering risk factors of premature mortality in common variable immunodeficiency","volume":"13","author":"Bez","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib23","unstructured":"Jeffrey Modell Foundation. 10 warning signs of primary immunodeficiency, Available at: https:\/\/info4pi.org\/library\/educational-materials\/ (Accessed 24 April 2026), 2024."},{"key":"10.1016\/j.iac.2026.06.011_bib31","doi-asserted-by":"crossref","unstructured":"Farmer JR, Ong MS, Barmettler S, et al. Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets, Front Immunol, 8, 2018, Available at: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2017.01740 (Accessed 24 April 2026).","DOI":"10.3389\/fimmu.2017.01740"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences","volume":"128","author":"S\u00e1nchez-Ram\u00f3n","year":"2008","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","article-title":"T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections","volume":"170","author":"Bateman","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib35","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-Cell and T-Cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2026.06.011_bib36","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"32","key":"10.1016\/j.iac.2026.06.011_bib93","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.iac.2026.06.011_bib94","article-title":"Loss of B cell tolerance at the T2\/T3a B cell transition is a convergent pathogenic mechanism in common variable immunodeficiency","author":"Hillier","year":"2025","journal-title":"BioRxiv Prepr Serv Biol"},{"key":"10.1016\/j.iac.2026.06.011_bib95","unstructured":"Leniolisib for immune dysregulation in CVID. ClinicalTrials.gov, Available at: https:\/\/www.clinicaltrials.gov\/study\/NCT06897358 (Accessed 24 April 2026), 2025."},{"key":"10.1016\/j.iac.2026.06.011_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103088","article-title":"Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation","volume":"140","author":"LaBere","year":"2023","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.iac.2026.06.011_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006269","article-title":"A decreased frequency of regulatory T cells in patients with common variable immunodeficiency","volume":"4","author":"Melo","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clim.2008.12.006","article-title":"Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease","volume":"131","author":"Yu","year":"2009","journal-title":"Clin Immunol Orlando Fla"},{"key":"10.1016\/j.iac.2026.06.011_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fimmu.2020.00006","article-title":"Functions of tfh cells in common variable immunodeficiency","volume":"11","author":"Le Saos-Patrinos","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib33","article-title":"Utility of serum cytokine testing to differentiate complicated common variable immunodeficiency in resource limited settings","volume":"4","author":"Jogdand","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib99","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.iac.2026.06.011_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1268207","article-title":"Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients","volume":"14","author":"Hanitsch","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib101","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s10875-020-00908-1","article-title":"Targeted proteomics reveals inflammatory pathways that classify immune dysregulation in common variable immunodeficiency","volume":"41","author":"Berbers","year":"2021","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib102","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10875-020-00947-8","article-title":"Soluble interleukin-2 receptor is a promising serum biomarker for granulomatous disease in common variable immune deficiency","volume":"41","author":"van Stigt","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib43","article-title":"Undetectable IgE association with noninfectious complications of common variable immune deficiency","author":"D\u2019Silva","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib24","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaci.2018.10.057","article-title":"Interlaboratory variability in multiplexed pneumococcal antibody testing","volume":"143","author":"LaFon","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.06.011_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2018.06.013","article-title":"Questioning the accuracy of currently available pneumococcal antibody testing","volume":"142","author":"Hajjar","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.06.011_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.15586\/aei.v50i4.496","article-title":"Application of the diagnostic criteria for common variable immunodeficiency in resource-limited settings","volume":"50","author":"\u00c1lvarez-\u00c1lvarez","year":"2022","journal-title":"Allergol Immunopathol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2017.12.980","article-title":"Update: vaccines in primary immunodeficiency","volume":"141","author":"Bonilla","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.06.011_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.anai.2025.10.026","article-title":"2025 inborn errors of immunity practice parameter","volume":"136","author":"Orange","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.anai.2024.12.011","article-title":"Functional testing of humoral immunity in the prevnar 20 era","volume":"134","author":"Zuzolo","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.857050","article-title":"Seeking relevant biomarkers in common variable immunodeficiency","volume":"13","author":"Ho","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib42","doi-asserted-by":"crossref","unstructured":"Poto R., Pecoraro A., Ferrara A.L., et al., Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID), Front Immunol, 14, 2023, Available at: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2023.1257398 (Accessed 24 April 2026).","DOI":"10.3389\/fimmu.2023.1257398"},{"issue":"9","key":"10.1016\/j.iac.2026.06.011_bib44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood.2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.iac.2026.06.011_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786516","article-title":"Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: experience from a monocentric study","volume":"12","author":"Rojas-Restrepo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib46","article-title":"Genetics and clinical phenotypes in common variable immunodeficiency","volume":"14","author":"Cunningham-Rundles","year":"2023","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaip.2024.11.011","article-title":"Disparities in genetic testing for inborn errors of immunity","volume":"13","author":"Gilbert","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib48","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","article-title":"Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency","volume":"152","author":"Taghizade","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2026.06.011_bib49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2022018546","article-title":"A randomized, placebo-controlled phase 3 trial of the PI3K\u03b4 inhibitor leniolisib for activated PI3K\u03b4 syndrome","volume":"141","author":"Rao","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib51","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib52","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/mus.25409","article-title":"Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: a meta-analysis","volume":"55","author":"Racosta","year":"2017","journal-title":"Muscle Nerve"},{"issue":"6 Suppl","key":"10.1016\/j.iac.2026.06.011_bib53","first-page":"S98","article-title":"Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin","volume":"25","author":"Ness","year":"2019","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.iac.2026.06.011_bib54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/PPA.S60771","article-title":"Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment","author":"Espanol","year":"2014","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/2047-783X-15-6-238","article-title":"Vivaglobin study group. Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency","volume":"15","author":"Hoffmann","year":"2010","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13223-024-00939-y","article-title":"Immunoglobulin replacement therapy in patients with primary and secondary immunodeficiencies: impact of infusion method on immunoglobulin-specific perceptions of quality of life and treatment satisfaction","volume":"21","author":"Mallick","year":"2025","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib57","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2500\/aap.2016.37.3987","article-title":"Intravenous and subcutaneous immunoglobulin G replacement therapy","volume":"37","author":"Bonilla","year":"2016","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.iac.2026.06.011_bib58","doi-asserted-by":"crossref","first-page":"c143","DOI":"10.1159\/000104424","article-title":"Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy","volume":"106","author":"Daphnis","year":"2007","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib59","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a work group report of the AAAAI primary immunodeficiency and altered immune response committees","volume":"149","author":"Otani","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2026.06.011_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100068","article-title":"Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: a systematic review and meta-analysis of clinical studies","volume":"12","author":"Shrestha","year":"2019","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2249.2012.04594.x","article-title":"Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy","volume":"169","author":"Orange","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10875-011-9631-6","article-title":"Higher doses of subcutaneous IgG reduce resource utilization in patients with primary immunodeficiency","volume":"32","author":"Haddad","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627423","article-title":"Granulomatous lymphocytic Interstitial Lung Disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from Italian PID referral centers","volume":"12","author":"Cinetto","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib65","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jinf.2017.10.017","article-title":"False positive serum levels of (1-3)-\u00df-D-Glucan after infusion of intravenous immunoglobulins and time to normalisation","volume":"76","author":"Egger","year":"2018","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/ciw222","article-title":"Transmission of hepatitis B core antibody and galactomannan enzyme immunoassay positivity via immunoglobulin products: a comprehensive analysis","volume":"63","author":"Ramsay","year":"2016","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"10","key":"10.1016\/j.iac.2026.06.011_bib67","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/1346-8138.16500","article-title":"Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseases","volume":"49","author":"Pruessmann","year":"2022","journal-title":"J Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2026.06.011_bib68","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1111\/ajt.15922","article-title":"Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab","volume":"20","author":"Jordan","year":"2020","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.iac.2026.06.011_bib70","unstructured":"Kroger A. and Murthy N., CDC yellow book: health information for international travel, Available at: https:\/\/www.cdc.gov\/yellow-book\/hcp\/preparing-international-travelers\/vaccination-and-immunoprophylaxis-general-principles.html (Accessed 24 April 2026), 2026."},{"key":"10.1016\/j.iac.2026.06.011_bib71","unstructured":"Benson C. and Brooks J., Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Infectious diseases Society of America; office of AIDS research advisory council, Available at: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/whats-new (Accessed 24 April 2026), 2025."},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib72","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/hematology.2020000117","article-title":"Preventing infections in children and adults with asplenia","volume":"2020","author":"Lee","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.iac.2026.06.011_bib73","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib74","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2022.12.813","article-title":"The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease","volume":"152","author":"Smits","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2026.06.011_bib75","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s10875-023-01587-4","article-title":"Rituximab monotherapy is effective as first-line treatment for granulomatous lymphocytic interstitial lung disease (GLILD) in CVID patients","volume":"43","author":"Tessarin","year":"2023","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib76","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib77","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2007.03481.x","article-title":"Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID)","volume":"150","author":"Chua","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib78","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/1756-0500-7-382","article-title":"Infliximab therapy for crohn\u2019s-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report","volume":"7","author":"Akazawa","year":"2014","journal-title":"BMC Res Notes"},{"issue":"7","key":"10.1016\/j.iac.2026.06.011_bib79","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s10875-014-0079-3","article-title":"Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency","volume":"34","author":"Franxman","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869466","article-title":"Autoimmune cytopenias in common variable immunodeficiency are a diagnostic and therapeutic conundrum: an update","volume":"13","author":"Chawla","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib81","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/1744666X.2023.2198208","article-title":"Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives","volume":"19","author":"Fevang","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-025-01920-z","article-title":"CVID enteropathy is difficult to treat and shows a heterogeneous histopathology","volume":"45","author":"Juliana","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common variable immunodeficiency: a systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib84","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaip.2016.08.004","article-title":"Mechanism-based strategies for the management of autoimmunity and immune dysregulation in primary immunodeficiencies","volume":"4","author":"Walter","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib85","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2015.08.036","article-title":"Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4","volume":"137","author":"Lee","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib86","article-title":"Congenital T cell activation impairs transitional to follicular B cell maturation in humans","author":"Allard-Chamard","year":"2024","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib87","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.jaci.2025.08.027","article-title":"Abatacept restores dysregulated transcriptomic and proteomic profile in disorders of CTLA-4 insufficiency","volume":"156","author":"Catak","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib88","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaci.2023.09.032","article-title":"Interim analysis: open-label extension study of leniolisib for patients with APDS","volume":"153","author":"Rao","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2025.09.021","article-title":"Hepatic manifestations in common variable immunodeficiency associated with mortality and worse Hospital outcomes in nationwide analysis using national readmission database","author":"Elmoursi","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib90","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib91","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","article-title":"Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects","volume":"23","author":"Piqueras","year":"2003","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.iac.2026.06.011_bib133","doi-asserted-by":"crossref","first-page":"102300","DOI":"10.1016\/j.coi.2023.102300","article-title":"T-bethighCD21low B cells: the need to unify our understanding of a distinct B cell population in health and disease","volume":"82","author":"Keller","year":"2023","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib96","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaci.2025.09.032","article-title":"Expansion of a distinct cytotoxic CD4 TFH-cell cluster in lymph nodes of patients with complicated common variable immunodeficiency","volume":"157","author":"Friedmann","year":"2026","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib97","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2021.06.008","article-title":"Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications","volume":"149","author":"Abyazi","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib98","doi-asserted-by":"crossref","first-page":"AB180","DOI":"10.1016\/j.jaci.2015.12.722","article-title":"Role of B cell activating factor in CVID lung disease","volume":"137","author":"Maglione","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib103","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.01.046","article-title":"Plasma protein profiling reflects T(H)1-driven immune dysregulation in common variable immunodeficiency","volume":"146","author":"Hultberg","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12864-022-08365-3","article-title":"Systematic benchmark of state-of-the-art variant calling pipelines identifies major factors affecting accuracy of coding sequence variant discovery","volume":"23","author":"Barbitoff","year":"2022","journal-title":"BMC Genom"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib105","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","article-title":"Genome-wide association identifies diverse causes of common variable immunodeficiency","volume":"127","author":"Orange","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fimmu.2020.00014","article-title":"Histocompatibility complex status and mendelian randomization analysis in unsolved antibody deficiency","volume":"11","author":"Abolhassani","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib107","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1038\/s41467-024-48527-3","article-title":"Cytomegalovirus drives V\u03b41+ \u03b3\u03b4 T cell expansion and clonality in common variable immunodeficiency","volume":"15","author":"Chan","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.iac.2026.06.011_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.107058","article-title":"Splenomegaly in CVID patients associates with CMV replication and alterations of immune cells and functions","volume":"276","author":"Marri","year":"2025","journal-title":"Immunol Lett"},{"issue":"5","key":"10.1016\/j.iac.2026.06.011_bib109","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaci.2012.02.011","article-title":"Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency","volume":"129","author":"Marashi","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-018-0574-z","article-title":"Autoimmunity and inflammation in CVID: a possible crosstalk between immune activation, gut microbiota, and epigenetic modifications","volume":"39","author":"J\u00f8rgensen","year":"2019","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib111","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ajg.2014.432","article-title":"The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency","volume":"110","author":"Woodward","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.iac.2026.06.011_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.70081","article-title":"CVID enteropathy associated with chronic norovirus infection: background, clinical features, and therapeutic aspects","volume":"35","author":"M\u0171zes","year":"2025","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-74728-3","article-title":"Revealing disease subtypes and heterogeneity in common variable immunodeficiency through transcriptomic analysis","volume":"14","author":"Zabihi","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.iac.2026.06.011_bib114","unstructured":"Abatacept for the treatment of common variable immunodeficiency with interstitial lung disease (ABCVILD). ClinicalTrials.gov, Available at: https:\/\/clinicaltrials.gov\/study\/NCT04925375?cond=CVID&term=Abatacept&rank=1 (Accessed 24 April 2026), 2025."},{"issue":"24","key":"10.1016\/j.iac.2026.06.011_bib115","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.jacc.2023.08.061","article-title":"Role of advanced practice providers in the cardiac intensive care unit team","volume":"82","author":"Tennyson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.iac.2026.06.011_bib116","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/jgs.15931","article-title":"Nurse practitioners and physician assistants: an underestimated workforce for older adults with cancer","volume":"67","author":"Coombs","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"10.1016\/j.iac.2026.06.011_bib117","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-159-9-201311050-00710","article-title":"Principles supporting dynamic clinical care teams: an American College of Physicians position paper","volume":"159","author":"Doherty","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2026.06.011_bib119","unstructured":"Government Accountability Office, Physician workforce: locations and types of graduate training were largely unchanged, and federal efforts may not be sufficient to meet needs\u202f: report to congressional requesters, Available at: http:\/\/resource.nlm.nih.gov\/101726977 (Accessed 24 April 2026), 2017."},{"issue":"4","key":"10.1016\/j.iac.2026.06.011_bib120","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2007.01.040","article-title":"The status of US allergy\/immunology physicians in the 21st century: a report from the American Academy of Allergy, Asthma & Immunology Workforce Committee","volume":"119","author":"Marshall","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.06.011_bib121","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaip.2023.11.030","article-title":"Rural health disparities in allergy, asthma, and immunologic diseases: the current state and future direction for clinical care and research","volume":"12","author":"Pongdee","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib122","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12913-019-4815-5","article-title":"Access to specialty healthcare in urban versus rural US populations: a systematic literature review","volume":"19","author":"Cyr","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"10.1016\/j.iac.2026.06.011_bib123","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.jaip.2022.06.025","article-title":"Telehealth and allergy services in rural and regional locations that lack specialty services","volume":"10","author":"Waibel","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib124","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/25785826.2022.2137966","article-title":"Physician awareness and understanding of primary immunodeficiency disorders: a web-based study in Japan","volume":"46","author":"Imai","year":"2023","journal-title":"Immunol Med"},{"issue":"3","key":"10.1016\/j.iac.2026.06.011_bib125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/bmjqs-2024-017506","article-title":"Experiences with diagnostic delay among underserved racial and ethnic patients: a systematic review of the qualitative literature","volume":"34","author":"Faugno","year":"2025","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2023.09.036","article-title":"Racial and ethnic disparities in early mortality among patients with inborn errors of immunity","volume":"153","author":"Ong","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2026.06.011_bib127","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.jaip.2021.03.021","article-title":"Clinical disparity of primary antibody deficiency patients at a safety net hospital","volume":"9","author":"Wallace","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2026.06.011_bib128","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fimmu.2020.00862","article-title":"Primary immunodeficiencies in a mesoregion of S\u00e3o Paulo, Brazil: Epidemiologic, clinical, and geospatial approach","volume":"11","author":"Boton Pereira","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.iac.2026.06.011_bib129","doi-asserted-by":"crossref","unstructured":"Al-Mousa H. and Al-Saud B., Primary immunodeficiency diseases in highly consanguineous populations from Middle East and North Africa: epidemiology, diagnosis, and care, Front Immunol, 8, 2017, Available at: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2017.00678 (Accessed 24 April 2026).","DOI":"10.3389\/fimmu.2017.00678"},{"issue":"745","key":"10.1016\/j.iac.2026.06.011_bib130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4510","article-title":"Electronic health record signatures identify undiagnosed patients with common variable immunodeficiency disease","volume":"16","author":"Johnson","year":"2024","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib131","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaci.2025.02.032","article-title":"A predictive model for identification of pediatric individuals with common variable immunodeficiency through electronic medical records","volume":"156","author":"Alsaati","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.06.011_bib132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s43856-023-00412-8","article-title":"Large-scale deep learning analysis to identify adult patients at risk for combined and common variable immunodeficiencies","volume":"3","author":"Papanastasiou","year":"2023","journal-title":"Commun Med"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:43:25Z","timestamp":1791575005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856126000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0889856126000664"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2026.06.011","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Phenotyping and Management of Common Variable Immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}